209 related articles for article (PubMed ID: 2138536)
21. Ca(2+)-dependent phospholipid and arachidonic acid binding by the placental annexins VI and IV.
Edwards HC; Crumpton MJ
Eur J Biochem; 1991 May; 198(1):121-9. PubMed ID: 1828227
[TBL] [Abstract][Full Text] [Related]
22. Characterizations of two distinct Ca2+-dependent phospholipid-binding proteins of 68-kDa isolated from human placenta.
Hayashi H; Owada MK; Sonobe S; Kakunaga T
J Biol Chem; 1989 Oct; 264(29):17222-30. PubMed ID: 2529258
[TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of phospholipase A2 by different lipocortins.
Weber G; Ferber E
Biol Chem Hoppe Seyler; 1990 Aug; 371(8):725-31. PubMed ID: 2144971
[TBL] [Abstract][Full Text] [Related]
24. Differential tissue expression of three 35-kDa annexin calcium-dependent phospholipid-binding proteins.
Kaetzel MA; Hazarika P; Dedman JR
J Biol Chem; 1989 Aug; 264(24):14463-70. PubMed ID: 2527237
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies to lipocortin-1 as probes for biological function.
Pepinsky RB; Sinclair LK; Dougas I; Liang CM; Lawton P; Browning JL
FEBS Lett; 1990 Feb; 261(2):247-52. PubMed ID: 1690147
[TBL] [Abstract][Full Text] [Related]
26. Five distinct calcium and phospholipid binding proteins share homology with lipocortin I.
Pepinsky RB; Tizard R; Mattaliano RJ; Sinclair LK; Miller GT; Browning JL; Chow EP; Burne C; Huang KS; Pratt D
J Biol Chem; 1988 Aug; 263(22):10799-811. PubMed ID: 2968983
[TBL] [Abstract][Full Text] [Related]
27. Lung calcium-dependent phospholipid-binding proteins: structure and function.
Tsao FH; Hull WM; Strickland MS; Whitsett JA; Foo TK; Zografi G; DeLuca PM
Biochim Biophys Acta; 1991 Jan; 1081(2):141-50. PubMed ID: 1998731
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant human lipocortin I.
Cartwright PH; Ilderton E; Sowden JM; Yardley HJ
Br J Dermatol; 1989 Aug; 121(2):155-60. PubMed ID: 2528367
[TBL] [Abstract][Full Text] [Related]
29. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH
FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817
[TBL] [Abstract][Full Text] [Related]
30. Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family.
Tait JF; Sakata M; McMullen BA; Miao CH; Funakoshi T; Hendrickson LE; Fujikawa K
Biochemistry; 1988 Aug; 27(17):6268-76. PubMed ID: 2975506
[TBL] [Abstract][Full Text] [Related]
31. Common domain structure of Ca2+ and lipid-binding proteins.
Geisow MJ
FEBS Lett; 1986 Jul; 203(1):99-103. PubMed ID: 2941317
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'.
Fradin A; Rothhut B; Poincelot-Canton B; Errasfa M; Russo-Marie F
Biochim Biophys Acta; 1988 Nov; 963(2):248-57. PubMed ID: 2848583
[TBL] [Abstract][Full Text] [Related]
33. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.
Wallner BP; Mattaliano RJ; Hession C; Cate RL; Tizard R; Sinclair LK; Foeller C; Chow EP; Browing JL; Ramachandran KL
Nature; 1986 Mar 6-12; 320(6057):77-81. PubMed ID: 2936963
[TBL] [Abstract][Full Text] [Related]
34. Purification of three forms of lipocortin from bovine lung.
Khanna NC; Tokuda M; Waisman DM
Cell Calcium; 1987 Jun; 8(3):217-28. PubMed ID: 2955902
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction.
Bastian BC; Sellert C; Seekamp A; Römisch J; Pâques EP; Bröcker EB
J Invest Dermatol; 1993 Sep; 101(3):359-63. PubMed ID: 8370974
[TBL] [Abstract][Full Text] [Related]
36. The receptors for ATP and fMetLeuPhe are independently coupled to phospholipases C and A2 via G-protein(s). Relationship between phospholipase C and A2 activation and exocytosis in HL60 cells and human neutrophils.
Cockcroft S; Stutchfield J
Biochem J; 1989 Nov; 263(3):715-23. PubMed ID: 2512911
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the antiinflammatory and phospholipase-inhibitory activity of calpactin II/lipocortin I.
Northup JK; Valentine-Braun KA; Johnson LK; Severson DL; Hollenberg MD
J Clin Invest; 1988 Oct; 82(4):1347-52. PubMed ID: 2971676
[TBL] [Abstract][Full Text] [Related]
38. Phospholipase A2 and lipocortin effects.
Dennis EA; Davidson FF
Prog Clin Biol Res; 1990; 349():47-54. PubMed ID: 2144646
[No Abstract] [Full Text] [Related]
39. Lipocortin-I inhibits the synthesis and release of prolactin from human decidual cells: evidence for autocrine/paracrine regulation by lipocortin-I.
Pihoker C; Feeney RJ; Su JL; Handwerger S
Endocrinology; 1991 Feb; 128(2):1123-8. PubMed ID: 1824932
[TBL] [Abstract][Full Text] [Related]
40. A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice.
Errasfa M; Russo-Marie F
Br J Pharmacol; 1989 Aug; 97(4):1051-8. PubMed ID: 2529014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
